Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pulmonary side effects of bleomycin therapy].

W Andler

    Klinische Padiatrie
    |January 1, 1984
    PubMed
    Summary

    Bleomycin is a key treatment for testicular cancers, but it can cause fatal lung fibrosis. This paper details a case study on bleomycin

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diagnostics and management of sleep-related respiratory disturbances in children with skeletal dysplasia caused by FGFR3 mutations (achondroplasia and hypochondroplasia).

    Georgian medical news·2011
    Same author

    Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study.

    Archives of disease in childhood·2009
    Same author

    Hemodynamic responses to exercise in obese children and adolescents before and after overweight reduction.

    Klinische Padiatrie·2009
    Same author

    Resistin concentrations before and after weight loss in obese children.

    International journal of obesity (2005)·2005
    Same author

    Circulating soluble leptin receptor, leptin, and insulin resistance before and after weight loss in obese children.

    International journal of obesity (2005)·2005
    Same author

    Clinical characteristics of type 2 diabetes mellitus in overweight European caucasian adolescents.

    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2005

    Area of Science:

    • Oncology
    • Pulmonology
    • Pharmacology

    Background:

    • Bleomycin is a standard chemotherapy agent for germinative scrotal tumors.
    • Its low bone marrow toxicity allows combination therapy for various cancers.
    • Pulmonary toxicity, including fatal lung fibrosis, is a known risk of Bleomycin therapy.

    Observation:

    • This paper presents a case study of a patient experiencing pulmonary side-effects from Bleomycin treatment.
    • The case highlights the potential for severe lung complications associated with this chemotherapy drug.

    Findings:

    • The observed case underscores the significant risk of pulmonary toxicity associated with Bleomycin.
    • Lung fibrosis is a critical adverse event that can occur during Bleomycin therapy.

    Implications:

    • Clinicians should be vigilant for pulmonary side-effects in patients receiving Bleomycin.
    • Further research into managing and preventing Bleomycin-induced lung fibrosis is warranted.
    • Risk-benefit assessments are crucial when using Bleomycin, especially in vulnerable patients.

    Related Experiment Videos